GLOBAL HEADQUATERS
Our Mission
"KHIDI’s mission is to promote the Korean healthcare Industry by supporting export and overseas marketing, the advancement of Korean healthcare services toward foreign patients, and the overseas expansion of healthcare service institutions.”
Our Vision
KHIDI envisions to be a professional institution that createssocial values and the future of the healthcare industry
Korea Healthcare Industry Landscape
Korea is one of the leading global economic powers with advanced technology, whose R&D investment as a proportion to the national GDP ranked as No.2 among OECD countries and the global market share of ICT (information and communication technology) products ranked as No.6. For the past 60 years, the export volume of Korean products has been rapidly increasing at the average annual rates of 16.9% (the world average: 5.4%). Among a number of industries that Korea takes lead in, the Korean government chose the healthcare industry as the next growth engine to open the ‘Post-IT industry’ era and established a systematic government support plan for industry promotion.
Pharmaceutical &
Biopharmaceutical
Korean pharmaceutical and biopharmaceutical industry is expected to play a greater role in the global market as globally competitive products and innovative technologies are constantly being developed. K-Pharma has achieved significant growth in the global pharmaceutical and biopharmaceutical industry and has become a global market player by establishing strategic alliances with multinational companies. Korean pharma and biopharma companies have developed highly specialized product portfolios.
Clinical
Trial
Among countries, Korea was ranked 6th in 2017 in the world by global clinical trial site numbers. Among cities, Seoul, the capital city of Korea, was ranked as No. 1 and 2 in the world by site number between 2013 and 2017, as Seoul is the home to many general hospitals with world-class facilities and professionals. Seoul has earned a reputation as one of the best cities to conduct clinical trials.
Impact on
Global market
Korean pharmaceutical products are increasingly making their presence in the global market; a significant increase in the export of biopharmaceuticals is leading the growth of total pharmaceutical exports. Japan has been Korea's biggest export market, and exports to Europe have risen significantly since EMA approval of biosimilars. Korean pharmaceutical market was valued at around $24.3 billion USD in 2019 which has been growing at a compound annual growth rate (CAGR) of 7.0% between 2015 and 2018.
Export Trends in the Healthcare Industry
(2000 - 2020)
KHIDI Programs
Supporting businesses throughout multiple business areas—from market entry to business development—KHIDI provides guidance for companies that are seeking opportunities in the US market or those that have interest in the Korean market.
Medical Korea
Medical Korea is a Korean national medical brand established to represent the excellence of Korea’s medical services. Medical Korea is also the title of the annual event held to promote the Korean medical industry, composed of conferences, exhibitions, and forums.
BioHealth
Innovation
Start-up Center
Biohealth Innovation Start-up Center serves as an accelerator for healthcare startups, providing support throughout all business cycles including technology and business consulting, company evaluation, business development, and funding.
Pharma
Korea
Pharma Korea is a platform that aims to enhance the development Korean pharmaceutical industry by providing consultation to Korean companies for global expansion while outlining domestic and global pharmaceutical industry trends.